REGN β€” REGENERON PHARMACEUTICALS

Ownership history in Headlands Technologies LLC  Β·  9 quarters on record

This page tracks every 13F SEC filing in which Headlands Technologies LLC reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.85% (2022 Q4)
πŸ“Š Avg. % of fund
0.52%
πŸ“… First filed
2022 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
9

Position Intelligence

Headlands Technologies LLC Γ— REGN AI Analytics

πŸ“‰ Headlands Technologies LLC underperformed the S&P 500 by –44.0% annually on this REGN position. Timing score: 57% (4/7 decisions correct). Average cost basis: $713.63. Maximum drawdown during holding period: –49.9%.

πŸ“ˆ Position Alpha vs SPY
-44.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 44.0% ann.
7 quarters analyzed

⏱️ Timing Score
57%

βœ… Decent timing β€” more right than wrong on entries and exits.
4 of 7 add/trim decisions correct

πŸ’° Entry Quality
$713.63
-21.4% vs current ($560.89)

Best entry: $522.92 (2025 Q2)  Β·  Worst: $1044.19 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–49.9%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
44%
buy-side decisions

4 adds Β· 5 trims. Bought during 1 of 3 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.18% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    REGN price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,014 -8,639 -68.3% 0.18% $2.3M $560.89
2025 Q2 ADDED 12,653 +9,259 +272.8% 0.80% $6.6M $522.92
2025 Q1 REDUCED 3,394 -1,997 -37.0% 0.25% $2.2M $630.78
2024 Q4 REDUCED 5,391 -201 -3.6% 0.39% $3.8M $707.55
2024 Q3 ADDED 5,592 +4,747 +561.8% 0.68% $5.9M $1044.19
2024 Q1 REDUCED 845 -398 -32.0% 0.20% $813K $956.03
2023 Q4 ADDED 1,243 +1,238 +24760.0% 0.33% $1.1M $872.40
2023 Q3 REDUCED 5 -3,230 -99.8% 0.00% $4K $817.44
2022 Q4 INITIATED 3,235 β€” β€” 1.85% $2.3M β€”

🏒 Other funds also holding REGN

As of 2025 Q4 β€” sorted by position size

Bronte Capital Management Pty Ltd. 3Y 7Y 13.61% Catawba River Capital 3Y 10.08% MCDONALD CAPITAL INVESTORS INC/CA 3Y 7Y 9.86% RK Asset Management, LLC 3Y 7Y 9.22% Orion Investment Co 7.25% SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 3Y 7Y 5.7% GuoLine Advisory Pte Ltd 4.78% Bronte Capital Management Pty Ltd. 3Y 7Y 4.57% Rhenman & Partners Asset Management AB 3Y 7Y 4.43% SOUND SHORE MANAGEMENT INC /CT/ 3Y 7Y 4.32%
← Back to Headlands Technologies LLC Holdings